Chroma, the UK’s leading provider of arts therapies, is to start a new six-month neuro-rehabilitation project at Sue Ryder Neurological Care Centre Lancashire, Preston.
Sue Ryder Neurological Care Centre Lancashire is a purpose-built, state of the art neurological care centre based in Eastway, which provides specialist neurological care, rehabilitation and support to people living with neurological conditions such as Parkinson’s disease, Huntington’s and multiple sclerosis as well as those with acquired brain injuries.
The project aims to improve patient outcomes and engagement in rehabilitation by establishing a Neurologic Music Therapy (NMT) service within the neuro-rehabilitation wards.
NMT uses musical elements such as rhythm, melody or pitch to treat diseases and injuries of the brain across the cognitive, sensorimotor, speech and language and affective domains try to change the brain’s impairment.
Chroma is the UK’s leading and only Ofsted registered national provider of arts therapy, using music, drama and visual arts to help people of all ages facing issues ranging from neurological damage such as dementia through to emotional and social problems.
Chroma will provide music therapy alongside other regulated therapies including occupational therapy, physiotherapy, and speech and language therapy, to clients being treated with brain injuries.
The Neuro-Rehabilitation Neurologic Music Therapy Project at the Sue Ryder Neurological Care Centre will build upon clinical/patient successes achieved by Chroma in other similar settings including Imperial College Healthcare NHS Trust, South Warwickshire NHS Foundation Trust and with private healthcare providers HCA Healthcare UK, Voyage Care.
Terry Mears, Centre Director at Sue Ryder Neurological Care Centre Lancashire added: “We are delighted to have Chroma on board to help support our neurological rehabilitation service. After a brain injury, so much is taken away from you and you can lose the confidence to communicate effectively. Working with Chroma, we can help our clients to improve their communication skills, independence, self-awareness and awareness of others plus support and improve their concentration and attention skills.
“This pilot project will provide scientifically validated clinical treatment whilst enabling staff to support patients and their families through the use of music in a non-clinical way. This allows us to continue our commitment to providing expert support and allowing us to be at the forefront of modernising neurological care across the county.”
Daniel Thomas, Managing Director of Chroma said: “We know how NMT can dramatically transform rehabilitation of brain injury survivors and we are really excited to be working with the team at the Sue Ryder Neurological Care Centre.
Daniel concluded: “The pilot will enable even more patients, carers, and staff to benefit from music therapy to enhance outcomes and patients’ engagement in their treatment and rehabilitation. Throughout the project, we aim to empower volunteers, next of kin and other nursing and care support staff to use music to promote recovery, strengthening the impact and sustainability of this project.”
